Listed pharmas’ stock prices dropped by 17% after Hanmi incident
Stock prices of listed pharmaceutical companies collapsed by 17% after the Hanmi Pharm crisis.
Moreover, approximately KRW 9 trillion was studied to evaporate from these listed pharmas’ market capitalization by the impact.
Since Hanmi Pharm signed an antibody technology license agreement of K...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
